Solid Biosciences Inc. SLDB Common Stock Issued As Payment For Developmental Milestone Consideration
Common Stock Issued As Payment For Developmental Milestone Consideration at other companies
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept sldb:CommonStockIssuedAsPaymentForDevelopmentalMilestoneConsideration.
The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Solid Biosciences Inc.'s common stock issued as payment for developmental milestone consideration.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Solid Biosciences Inc.'s common stock issued as payment for developmental milestone consideration?
- Solid Biosciences Inc. (SLDB) reported common stock issued as payment for developmental milestone consideration of $7.5M in Q1 2026.
- How has Solid Biosciences Inc.'s common stock issued as payment for developmental milestone consideration changed year-over-year?
- Solid Biosciences Inc.'s common stock issued as payment for developmental milestone consideration increased by 50.0% year-over-year, from $5M to $7.5M.
- What does common stock issued as payment for developmental milestone consideration mean?
- Represents the non-cash issuance of equity shares to third parties as consideration for achieving specific developmental or clinical milestones. This metric highlights the use of equity as a strategic currency to incentivize partners without depleting cash reserves.